Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Novo Seeds
Deal Size : $10.6 million
Deal Type : Series A Financing
Details : Rappta has developed proprietary tools and a unique understanding of PP2A which allows it to therapeutically reactivate PP2A.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 13, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Novo Seeds
Deal Size : $10.6 million
Deal Type : Series A Financing